172 related articles for article (PubMed ID: 22942745)
1. Binding mode pediction of evodiamine within vanilloid receptor TRPV1.
Wang Z; Sun L; Yu H; Zhang Y; Gong W; Jin H; Zhang L; Liang H
Int J Mol Sci; 2012; 13(7):8958-8969. PubMed ID: 22942745
[TBL] [Abstract][Full Text] [Related]
2. Evodiamine functions as an agonist for the vanilloid receptor TRPV1.
Pearce LV; Petukhov PA; Szabo T; Kedei N; Bizik F; Kozikowski AP; Blumberg PM
Org Biomol Chem; 2004 Aug; 2(16):2281-6. PubMed ID: 15305207
[TBL] [Abstract][Full Text] [Related]
3. Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels.
De Petrocellis L; Schiano Moriello A; Fontana G; Sacchetti A; Passarella D; Appendino G; Di Marzo V
Br J Pharmacol; 2014 May; 171(10):2608-20. PubMed ID: 23902373
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine and rutaecarpine alkaloids as highly selective transient receptor potential vanilloid 1 agonists.
Ivanova B; Spiteller M
Int J Biol Macromol; 2014 Apr; 65():314-24. PubMed ID: 24495556
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
Feng Z; Pearce LV; Xu X; Yang X; Yang P; Blumberg PM; Xie XQ
J Chem Inf Model; 2015 Mar; 55(3):572-88. PubMed ID: 25642729
[TBL] [Abstract][Full Text] [Related]
6. Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin.
Elokely K; Velisetty P; Delemotte L; Palovcak E; Klein ML; Rohacs T; Carnevale V
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E137-45. PubMed ID: 26719417
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies.
Lee JH; Lee Y; Ryu H; Kang DW; Lee J; Lazar J; Pearce LV; Pavlyukovets VA; Blumberg PM; Choi S
J Comput Aided Mol Des; 2011 Apr; 25(4):317-27. PubMed ID: 21448716
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine suppresses capsaicin-induced thermal hyperalgesia through activation and subsequent desensitization of the transient receptor potential V1 channels.
Iwaoka E; Wang S; Matsuyoshi N; Kogure Y; Aoki S; Yamamoto S; Noguchi K; Dai Y
J Nat Med; 2016 Jan; 70(1):1-7. PubMed ID: 26188960
[TBL] [Abstract][Full Text] [Related]
9. Partial Activation and Inhibition of TRPV1 Channels by Evodiamine and Rutaecarpine, Two Major Components of the Fruits of Evodia rutaecarpa.
Wang S; Yamamoto S; Kogure Y; Zhang W; Noguchi K; Dai Y
J Nat Prod; 2016 May; 79(5):1225-30. PubMed ID: 27159637
[TBL] [Abstract][Full Text] [Related]
10. Understand spiciness: mechanism of TRPV1 channel activation by capsaicin.
Yang F; Zheng J
Protein Cell; 2017 Mar; 8(3):169-177. PubMed ID: 28044278
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin.
Li Y; Chen X; Nie Y; Tian Y; Xiao X; Yang F
J Biol Chem; 2021 Sep; 297(3):101022. PubMed ID: 34332978
[TBL] [Abstract][Full Text] [Related]
12. A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds.
Caballero J
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2169-2178. PubMed ID: 35975286
[TBL] [Abstract][Full Text] [Related]
13. Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis.
Wei J; Ching LC; Zhao JF; Shyue SK; Lee HF; Kou YR; Lee TS
Acta Physiol (Oxf); 2013 Feb; 207(2):299-307. PubMed ID: 23025809
[TBL] [Abstract][Full Text] [Related]
14. Detailed Analysis of the Binding Mode of Vanilloids to Transient Receptor Potential Vanilloid Type I (TRPV1) by a Mutational and Computational Study.
Ohbuchi K; Mori Y; Ogawa K; Warabi E; Yamamoto M; Hirokawa T
PLoS One; 2016; 11(9):e0162543. PubMed ID: 27606946
[TBL] [Abstract][Full Text] [Related]
15. Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase.
Ching LC; Chen CY; Su KH; Hou HH; Shyue SK; Kou YR; Lee TS
Mol Med; 2012; 18(1):805-15. PubMed ID: 22451268
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of conformationally restricted capsaicin analogues based in the 1, 3, 4-thiadiazole heterocycle reveal a novel family of transient receptor potential vanilloid 1 (TRPV1) antagonists.
Rebolledo CL; Sotelo-Hitschfeld P; Brauchi S; Olavarría MZ
Eur J Med Chem; 2013 Aug; 66():193-203. PubMed ID: 23796768
[TBL] [Abstract][Full Text] [Related]
17. Identification of voltage-gated K(+) channel beta 2 (Kvβ2) subunit as a novel interaction partner of the pain transducer Transient Receptor Potential Vanilloid 1 channel (TRPV1).
Bavassano C; Marvaldi L; Langeslag M; Sarg B; Lindner H; Klimaschewski L; Kress M; Ferrer-Montiel A; Knaus HG
Biochim Biophys Acta; 2013 Dec; 1833(12):3166-3175. PubMed ID: 24036102
[TBL] [Abstract][Full Text] [Related]
18. Structure-Driven Pharmacology of Transient Receptor Potential Channel Vanilloid 1.
Díaz-Franulic I; Caceres-Molina J; Sepulveda RV; Gonzalez-Nilo F; Latorre R
Mol Pharmacol; 2016 Sep; 90(3):300-8. PubMed ID: 27335334
[TBL] [Abstract][Full Text] [Related]
19. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
[TBL] [Abstract][Full Text] [Related]
20. Binding of Capsaicin to the TRPV1 Ion Channel.
Darré L; Domene C
Mol Pharm; 2015 Dec; 12(12):4454-65. PubMed ID: 26502196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
